[Serum CA 125 and TPA determination in malignant neoplasms of the uterus].
Gadducci
A
A
Facchini
V
V
Bartolini
T
T
Fioretti
P
P
D000230:Adenocarcinoma / Q000175:diagnosis* / Q000276:immunology; D000951:Antigens, Neoplasm / Q000032:analysis*; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000032:analysis*; D014408:Biomarkers, Tumor; D002294:Carcinoma, Squamous Cell / Q000175:diagnosis* / Q000276:immunology; D005260:Female; D006801:Humans; D010455:Peptides / Q000032:analysis*; D019396:Tissue Polypeptide Antigen; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis / Q000276:immunology; D014594:Uterine Neoplasms / Q000175:diagnosis* / Q000276:immunology
D000951:Antigens, Neoplasm; D015295:Antigens, Tumor-Associated, Carbohydrate; D014408:Biomarkers, Tumor; D010455:Peptides; D019396:Tissue Polypeptide Antigen
Il dosaggio sierico del CA125 e del TPA nelle neoplasie maligne dell'utero.